 |
Recombinant human C1-esterase inhibitor |
|---|---|
| Trade Name | |
| Orphan Indication | Hereditary angioedema |
| USA Market Approval | USA |
| USA Designation Date | 1999-02-23 00:00:00 |
| Sponsor | Pharming Group N.V.;P. O. Box 451 Darwinweg 24, 2300 Al Leiden;Leiden |
Related Access Program